← Back to Search

Alkylating agents

nab-Paclitaxel + Cisplatin + Gemcitabine for Pancreatic Cancer

Phase 2
Waitlist Available
Led By Gayle Jameson, ACNP-BC
Research Sponsored by HonorHealth Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 360 days
Awards & highlights

Study Summary

This trial tests a new treatment for advanced pancreatic cancer to see if it's effective and safe.

Eligible Conditions
  • Pancreatic Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~360 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 360 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
12- Month Overall Survival
Secondary outcome measures
Change in tumor markers
Disease Response
Pain Control: Brief Pain Inventory (BPI)
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: NabCGExperimental Treatment1 Intervention
nab-paclitaxel 125mg/m2 cisplatin 25 mg/m2 gemcitabine 1000 mg/m2, all administered intravenously (IV) on Days 1 and 8 every 21 days

Find a Location

Who is running the clinical trial?

CelgeneIndustry Sponsor
635 Previous Clinical Trials
128,893 Total Patients Enrolled
HonorHealth Research InstituteLead Sponsor
25 Previous Clinical Trials
864 Total Patients Enrolled
Gayle Jameson, ACNP-BCPrincipal InvestigatorHonorHealth Research Institute
1 Previous Clinical Trials
1 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Nab-Paclitaxel + Cisplatin + Gemcitabine in Untreated Metastatic Pancreatic Adenocarcinoma
2019. "Nab-Paclitaxel + Cisplatin + Gemcitabine in Untreated Metastatic Pancreatic Adenocarcinoma". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03915444.
~7 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top